| ENG

All

Shared Instrumentation Grant (SIG) Program (S10) - PAR-16-054
January 5,2016

Shared Instrumentation Grant (SIG) Program (S10) - PAR-16-054

The Shared Instrument Grant (SIG) program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000. The maximum award is $600,000. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers.

U.S.-China Program for Biomedical Collaborative Research (R01) - NIH
January 5,2016

U.S.-China Program for Biomedical Collaborative Research (R01) - NIH

The purpose of the U.S.-China Program for Biomedical Collaborative Research is to stimulate collaborative basic, translational, and clinical research between United States (U.S.)-based researchers and Chinese researchers in the areas of allergy, immunology, and infectious diseases including HIV/AIDS and its co-morbidities and co-infections, mental health, and selected neurological disorders.

A16-014	Laser Nanostructured Surfaces for Armament Applications
January 4,2016

A16-014 Laser Nanostructured Surfaces for Armament Applications

To develop laser nanostructuring technologies for durable, anti-corrosive, self-cleaning, hydrophobic surfaces.

NIH: Type 1 Diabetes - Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies
November 24,2015

NIH: Type 1 Diabetes - Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of innovative technologies that may advance progress toward more effective cell replacement therapies for type 1 diabetes (T1D).

2015-August US Patent Applications: Sol-Gel
September 9,2015

2015-August US Patent Applications: Sol-Gel

Sol-Gel Technologies, Products and Processes

DOE 26. LASER TECHNOLOGY R&D FOR ACCELERATORS
December 2,2015

DOE 26. LASER TECHNOLOGY R&D FOR ACCELERATORS

This topic area is aimed at developing technologies for ultrafast lasers capable of high average power (kilowatt-class) operating at the high electrical-to-optical efficiency (>20%) needed for advanced accelerator applications.

DOE 20d. Structural Materials and Coatings
December 2,2015

DOE 20d. Structural Materials and Coatings

An attractive fusion energy source will require the development of superconducting magnets and materials as well as technologies that can withstand the high levels of surface heat flux and neutron wall loads expected for the in-vessel components of future fusion energy systems. These technologies and materials will need to be substantially advanced relative to today's capabilities in order to achieve safe, reliable, economic, and environmentally-benign operation of fusion energy systems.

DOE 20c. Superconducting Magnets and Materials
December 2,2015

DOE 20c. Superconducting Magnets and Materials

An attractive fusion energy source will require the development of superconducting magnets and materials as well as technologies that can withstand the high levels of surface heat flux and neutron wall loads expected for the in-vessel components of future fusion energy systems. These technologies and materials will need to be substantially advanced relative to today's capabilities in order to achieve safe, reliable, economic, and environmentally-benign operation of fusion energy systems